drugset / Trial / NCT00439400
A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period
RandomizedParallel-groupDouble-blind
Summary
The objective of this study is to assess the safety and efficacy of doxycycline 0.025% (ALTY-0501) ophthalmic solution for the treatment of dry eye using the Controlled Adverse Environment (CAE) Model.
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxycycline | Small molecule | 0.025 % | Topical |